Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 769830, 10 pages
http://dx.doi.org/10.1155/2012/769830
Research Article

Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease

1Department of Oriental Physiology, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
2Division of Pharmacognosy, College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea
3Department of Life and Nanopharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea
4Division of Allergy and Respiratory System, Department of Oriental Internal Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea

Received 5 October 2011; Accepted 28 February 2012

Academic Editor: Xiu-Min Li

Copyright © 2012 Hyojung Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Mannino and A. S. Buist, “Global burden of COPD: risk factors, prevalence, and future trends,” The Lancet, vol. 370, no. 9589, pp. 765–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. R. A. Pauwels and K. F. Rabe, “Burden and clinical features of chronic obstructive pulmonary disease (COPD),” The Lancet, vol. 364, no. 9434, pp. 613–620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. A. Calverley and P. Walker, “Chronic obstructive pulmonary disease,” The Lancet, vol. 362, no. 9389, pp. 1053–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. M. Siafakas, P. Vermeire, N. B. Pride et al., “Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force,” European Respiratory Journal, vol. 8, no. 8, pp. 1398–1420, 1995. View at Google Scholar
  5. J. George, L. L. Ioannides-Demos, N. M. Santamaria, D. C. M. Kong, and K. Stewart, “Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease,” Medical Journal of Australia, vol. 181, no. 5, pp. 248–251, 2004. View at Google Scholar · View at Scopus
  6. N. Shinozuka, K. Tatsumi, A. Nakamura, J. Terada, and T. Kuriyama, “The traditional herbal medicine hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease,” Journal of the American Geriatrics Society, vol. 55, no. 2, pp. 313–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. Calixto, M. M. Campos, M. F. Otuki, and A. R. S. Santos, “Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules,” Planta Medica, vol. 70, no. 2, pp. 93–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Guo, M. H. Pittler, and E. Ernst, “Herbal medicines for the treatmet of COPD:a systematic review,” European Respiratory Journal, vol. 28, no. 2, pp. 330–338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. S. Roh, S. W. Seo, S. Yeo et al., “Efficacy of a traditional Korean medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma,” International Immunopharmacology, vol. 5, no. 2, pp. 427–436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Puljic, E. Benediktus, C. Plater-Zyberk et al., “Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF,” European Journal of Pharmacology, vol. 557, no. 2-3, pp. 230–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gharaee-Kermani, M. Ullenbruch, and S. H. Phan, “Animal models of pulmonary fibrosis,” Methods in Molecular Medicine, vol. 117, pp. 251–259, 2005. View at Google Scholar · View at Scopus
  12. W. Hsueh, X. Sun, L. N. Rioja, and F. Gonzalez-Crussi, “The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin,” Immunology, vol. 70, no. 3, pp. 309–314, 1990. View at Google Scholar · View at Scopus
  13. D. F. Rogers, “Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy,” Monaldi Archives for Chest Disease, vol. 55, no. 4, pp. 324–332, 2000. View at Google Scholar · View at Scopus
  14. P. J. Barnes, “Mechanisms in COPD: differences from asthma,” Chest, vol. 117, no. 2, 2000. View at Google Scholar · View at Scopus
  15. H. J. Kim and Y. P. Jang, “Direct analysis of curcumin in turmeric by DART-MS,” Phytochemical Analysis, vol. 20, no. 5, pp. 372–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Sajjan, S. Ganesan, A. T. Comstock et al., “Elastase- and LPS-exposed mice display altered responses to rhinovirus infection,” American Journal of Physiology, vol. 297, no. 5, pp. L931–L944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Van Grunsven, C. P. Van Schayck, J. P. Derenne et al., “Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis,” Thorax, vol. 54, no. 1, pp. 7–14, 1999. View at Google Scholar · View at Scopus
  18. S. L. Li, J. Z. Song, C. F. Qiao, Y. Zhou, and H. X. Xu, “UPLC-PDA-TOFMS based chemical profiling approach to rapidly evaluate chemical consistency between traditional and dispensing granule decoctions of traditional medicine combinatorial formulae,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, no. 4, pp. 468–478, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Pilli, G. B. Rosso, and M. D. C. F. De Oliveira, “The Stemona Alkaloids,” Alkaloids, vol. 62, pp. 77–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. J. Kim, M. S. Oh, J. Hong, and Y. P. Jang, “Quantitative analysis of major dibenzocyclooctane lignans in schisandrae fructus by online TLC-DART-MS,” Phytochemical Analysis, vol. 22, no. 3, pp. 258–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Houghton, P. A. Quintero, D. L. Perkins et al., “Elastin fragments drive disease progression in a murine model of emphysema,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 753–759, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Y. Lee, H. H. Chang, J. H. Chen, M. L. Hsueh, and J. J. Kuo, “Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats,” Journal of Ethnopharmacology, vol. 109, no. 2, pp. 318–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. H. Wang and S. P. Hogan, “Chinese herbal anti-asthma tea to go!,” Clinical and Experimental Allergy, vol. 40, no. 11, pp. 1590–1592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. D. Hasday, R. Bascom, J. J. Costa, T. Fitzgerald, and W. Dubin, “Bacterial endotoxin is an active component of cigarette smoke,” Chest, vol. 115, no. 3, pp. 829–835, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. K. F. Chung, “Cytokines in chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 18, supplement 34, pp. 50s–59s, 2001. View at Google Scholar · View at Scopus
  26. E. M. Drost and W. MacNee, “Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis,” European Journal of Immunology, vol. 32, no. 2, pp. 393–403, 2002. View at Google Scholar
  27. G. Lungarella, E. Cavarra, M. Lucattelli, and P. A. Martorana, “The dual role of neutrophil elastase in lung destruction and repair,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1287–1296, 2008. View at Publisher · View at Google Scholar · View at Scopus